ICLR
ICON Public Limited Company
NASDAQ · Healthcare · Medical - Diagnostics & Research · IE
$164.85
+0.78%Year over year
Reported trailing growth
- Revenue
- +2.0%
- EBITDA
- -9.3%
- EBIT
- -17.2%
- EPS
- -56.1%
- Free cash flow
- +34.2%
- Operating cash flow
- +38.4%
Forward estimates
Based on analyst estimates
- Revenue
- -1.1%
- EBITDA
- +21.6%
- EPS
- +159.6%
Three-year CAGR
- Revenue
- +2.1%
- EBITDA
- -16.5%
- EBIT
- +8.4%
- Net income
- -23.2%
- EPS
- -22.2%
- Free cash flow
- +27.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026